|
|
|
Volumn 17, Issue 10, 2012, Pages 1-4
|
|
Rosacea: update on management and emerging therapies.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENERGIC RECEPTOR STIMULATING AGENT;
ANTIINFECTIVE AGENT;
ANTIPARASITIC AGENT;
AZELAIC ACID;
BRIMONIDINE;
DERMATOLOGICAL AGENT;
DICARBOXYLIC ACID;
DOXYCYCLINE;
IVERMECTIN;
METRONIDAZOLE;
OXYMETAZOLINE;
QUINOXALINE DERIVATIVE;
SULFACETAMIDE;
ARTICLE;
FEMALE;
HUMAN;
INTRADERMAL DRUG ADMINISTRATION;
MALE;
PATHOPHYSIOLOGY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ROSACEA;
TREATMENT OUTCOME;
ADMINISTRATION, CUTANEOUS;
ADRENERGIC AGENTS;
ANTI-INFECTIVE AGENTS;
ANTIPARASITIC AGENTS;
DERMATOLOGIC AGENTS;
DICARBOXYLIC ACIDS;
DOXYCYCLINE;
FEMALE;
HUMANS;
IVERMECTIN;
MALE;
METRONIDAZOLE;
OXYMETAZOLINE;
QUALITY OF LIFE;
QUINOXALINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
ROSACEA;
SULFACETAMIDE;
TREATMENT OUTCOME;
|
|
EID: 84874796449
PISSN: 12015989
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (19)
|
|
References (0)
|
